Cognitive and neuroradiological improvement in three patients with attenuated MPS I treated by laronidase.

[1]  D. Rapoport,et al.  Long-term Efficacy and Safety of Laronidase in the Treatment of Mucopolysaccharidosis I , 2009, Pediatrics.

[2]  F. Donnerstag,et al.  Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot study , 2007, Developmental medicine and child neurology.

[3]  J. E. Wraith,et al.  Enzyme Replacement Therapy in Patients Who Have Mucopolysaccharidosis I and Are Younger Than 5 Years: Results of a Multinational Study of Recombinant Human α-l-Iduronidase (Laronidase) , 2007, Pediatrics.

[4]  A. Fischer,et al.  Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure , 2007, Bone Marrow Transplantation.

[5]  R. Hoft,et al.  A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. , 2007, Molecular genetics and metabolism.

[6]  R. Watts,et al.  Neuropathological and clinical correlations in hurler disease , 1986, Journal of Inherited Metabolic Disease.

[7]  M. Poe,et al.  Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. , 2004, The New England journal of medicine.

[8]  Joseph Muenzer,et al.  Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). , 2004, The Journal of pediatrics.

[9]  H. Hoshi,et al.  Evaluation of Accumulated Mucopolysaccharides in the Brain of Patients with Mucopolysaccharidoses by 1H-Magnetic Resonance Spectroscopy before and after Bone Marrow Transplantation , 2001, Pediatric Research.

[10]  J. Belmont,et al.  Enzyme-replacement therapy in mucopolysaccharidosis I. , 2001, The New England journal of medicine.

[11]  W. Krivit,et al.  Hurler syndrome: past, present, and future. , 1998, The Journal of pediatrics.

[12]  J. Wagner,et al.  Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. , 1998, Blood.

[13]  V. Runge,et al.  The mucopolysaccharidoses: characterization by cranial MR imaging. , 1993, AJNR. American journal of neuroradiology.

[14]  A. J. Levens.  Progress in Neuropathology. Vol. III , 1978 .

[15]  M. Herman,et al.  Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain. , 1976, Archives of pathology & laboratory medicine.